Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01199666 · ClinicalTrials.gov registry record · NA

Text Message Reminder-Recalls For Early Childhood Vaccination

A NA study of Vaccination, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
2,586
Enrollment target
1
Study location

NCT01199666: Completed NA study of Vaccination, sponsored by Columbia University.

NCT01199666 is a NA study of Vaccination that has completed, run by Columbia University. The registered enrollment target is 2,586 participants, below the 10,018-participant average among 12 other Vaccination trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01199666, a NA study of Vaccination, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
2,586 participants
Enrollment target
1
Study location

Study Summary

Although the investigators have reached the Healthy People 2010 goal of 80% coverage among U.S. children 19-35 months of age for the primary immunization series, 20% of children still remain underimmunized. In addition, pockets of low immunization coverage and outbreaks of vaccine preventable disease persist. Immunization reminder-recalls have been shown to be successful, but have been limited by the ability to identify and reach large target populations in a real-time, automated fashion. Reminder-recalls via text message may offer an innovative opportunity to improve vaccination coverage. Currently, 91% of Americans own a cell phone. Prior research by our team suggests that text messages reminder recalls may be an effective tool to remind parents about their children's vaccines. In this study, the investigators will demonstrate the effectiveness of tailored text message appointment and immunization reminders linked to a well-established and functional immunization registry to increase coverage rates and timeliness of the sentinel vaccines of MMR and HepA. The investigators will target parents of young children from an underserved population that is primarily Latino, with low socioeconomic status.

Conditions Studied

Interventions

  • OTHER Text message

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 2,586 participants
Start Date 2011-06
Est. Completion 2013-07
Phase NA
Columbia University

958 total trials

What the finished NCT01199666 record still lists

NCT01199666 is an interventional study that assigns participants to a tested intervention. Its 2,586 participants enrollment target places it among the larger protocols in the corpus, below the 10,018-participant average among 12 other Vaccination trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Text message is the first listed.

NCT01199666 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01199666 about?

NCT01199666 is a clinical study titled "Text Message Reminder-Recalls For Early Childhood Vaccination". Although the investigators have reached the Healthy People 2010 goal of 80% coverage among U.S. children 19-35 months of age for the primary immunization series, 20% of children still remain underimmunized. In addition, pockets of low immunization coverage and outbreaks of vaccine preventable diseas...

What is the current status of trial NCT01199666?

This trial is currently completed. It is a NA study. The enrollment target is 2,586 participants. The study started on 2011-06. Estimated completion is 2013-07.

What conditions does trial NCT01199666 study?

This clinical trial studies the following conditions: Vaccination.

What interventions are being tested in trial NCT01199666?

The interventions under investigation include: Text message (OTHER).

Who is sponsoring clinical trial NCT01199666?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01199666 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01199666's enrollment target sits among peer trials

2,586 4th of 12 higher than 9 of 12 other Vaccination trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Vaccination trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06370520 · 2,592 participants

    Screening Emotions in Adolescents at the Hospital for mTBI

  • NCT06033950 · 2,600 participants · Phase 3

    A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

  • NCT06574672 · 2,600 participants · NA

    Embedded Palliative Care in the MICU

  • NCT06018285 · 2,572 participants · NA

    Stepped Approach to Reducing Risk of Suicide in Primary Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01199666, the US trial registry maintained by the National Library of Medicine. NCT01199666 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.